Opens in a new tab or window SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body ...

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent ...

The drugmaker kept a lid on advertising Zepbound in the meantime ... All of them said they are still seeing intense demand ...

Mounjaro and Zepbound. The medical news website Medscape first reported the warning label update on Wednesday. GLP-1s — which ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

But after gaining more than 20 pounds during undergraduate and graduate school and feeling unhappy with her weight, the ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

Read More: No One Knows How to Talk About Weight Loss Anymore Millions of people in the U.S.—about 6% of the adult population ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Zepbound, at a fraction of the branded cost, but with little known about their efficacy or safety. Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because ...